EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain

Ti-Chuan Chiu, Yu-Yu Li, Chia-Hung Yu, Kuo-Chuan Hung, Chin-Chen Chu, Ping-Hsun Feng, Ping-Heng Tan

Journal of Integrative Neuroscience · 23.06.2025 · 24 (6)

DOI: 10.31083/jin33414 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Integrative Neuroscience, online erschienen am 23.06.2025. Verfasst von Ti-Chuan Chiu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Chi Mei Medical Center, 701 Tainan, Taiwan, ROC. Hauptthemen laut MEDLINE: Signal Transduction, Membrane Proteins, Interferon Type I, Nociception. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Chi-Mei Hospital Grants.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Interferons (IFNs) are cytokines with diverse functions, possessing antiviral, antiproliferative, and immunomodulatory effects. IFN-α and IFN-β, key members of the type I interferon (IFN-I) family, are widely used in the treatment of diseases such as hepatitis and multiple sclerosis. In the nervous system, microglia, astrocytes, and neurons express IFN-I receptors. Beyond their classical transcriptional roles, IFN-Is can suppress neuronal activity and synaptic transmission through nongenomic mechanisms, producing potent analgesic effects. However, IFN-Is are active in signaling pathways such as phosphoinositide 3-kinase (PI3K), mitogen-activated protein kinase (MAPK), and the MAPK-interacting serine/threonine-protein kinase (MNK)-eukaryotic initiation factor 4E (eIF4E) pathway, which can sensitize peripheral nociceptors and contribute to nociceptive responses. This narrative review explores recent advances in understanding the roles of IFN-I and the cyclic-GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) signaling cascade in acute and chronic nociceptive responses, which are increasingly recognized but remain a subject of debate. Recent studies suggest that the STING–IFN-I pathway has complex, stage-dependent effects on nociception. In the middle to late stages of the nociceptive response, this pathway can activate signal transducer and activator of transcription (STAT) signaling, as well as microglial mediated STING pathways and tumor necrosis factor (TNF) receptor-associated factor (TRAF) family member-associated nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB activator) collectively referred to as TANK. These pathways increase pro- and anti-inflammatory cytokine production, promote microglial M1 polarization, and inhibit endoplasmic reticulum-phagy (ER-phagy) in the central nervous system (CNS). These mechanisms contribute to central sensitization while modulating the analgesic effects of IFN-Is. Thus, the STING-IFN-I pathway plays a dual role in nociception, with both pro-nociceptive and analgesic effects that are dependent on the stage of the nociceptive response. Understanding the differential roles of STING–IFN-I signaling in nociceptors under physiological and pathological conditions could pave the way for the development of targeted nociceptive response management therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionMembrane ProteinsInterferon Type INociceptionPainHumansAnimalsSTING Protein

Stichwörter der Autor:innen

IFN-αIFN-βSTINGnociceptive responsetype I interferontype I interferon receptor

Substanzen

Membrane ProteinsInterferon Type ISTING1 protein, humanSTING Protein

Autor:innen und Institutionen

  • Department of Anesthesiology, Chi Mei Medical Center, 701 Tainan, Taiwan, ROC.
  • Department of Anesthesiology, Chi-Mei Hospital, Chiali, 722 Tainan, Taiwan, ROC.
  • Department of Leisure and Sports Management, CTBC University of Technology, 744 Tainan, Taiwan, ROC.
  • School of Medicine, College of Medicine, National Sun Yat-Sen University, 800 Kaohsiung, Taiwan, ROC.
  • Department of Anesthesiology, Chi Mei Medical Center, Liouying, 736 Tainan, Taiwan, ROC.

Förderung

  • National Science and Technology Council
  • Chi-Mei Hospital Grants

Zitieren

APA

Chiu, T. C., Li, Y. Y., Yu, C. H., Hung, K. C., Chu, C. C., Feng, P. H., & Tan, P. H. (2025). Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain. Journal of Integrative Neuroscience, 24(6). https://doi.org/10.31083/jin33414

Vancouver

Chiu TC, Li YY, Yu CH, Hung KC, Chu CC, Feng PH, et al. Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain. Journal of Integrative Neuroscience. 2025;24(6). doi:10.31083/jin33414

BibTeX
@article{Chiu2025,
  author = {Chiu, Ti-Chuan and Li, Yu-Yu and Yu, Chia-Hung and Hung, Kuo-Chuan and Chu, Chin-Chen and Feng, Ping-Hsun and Tan, Ping-Heng},
  title = {Stimulator of Interferon Genes (STING)-Type I Interferon Signaling: Bridging Immunity and Pain},
  journal = {Journal of Integrative Neuroscience},
  year = {2025},
  volume = {24},
  number = {6},
  doi = {10.31083/jin33414}
}
Kostenlos starten →